Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Allarity Therapeutics (ALLR) EBT Margin (2024 - 2025)

Allarity Therapeutics' EBT Margin history spans 2 years, with the latest figure at 3891.53% for Q4 2025.

  • For Q4 2025, EBT Margin rose 800581.0% year-over-year to 3891.53%; the TTM value through Dec 2025 reached 2989.19%, up 168444.0%, while the annual FY2025 figure was 1738.12%, N/A changed from the prior year.
  • EBT Margin reached 3891.53% in Q4 2025 per ALLR's latest filing, down from 4922.81% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 23934.0% in Q3 2024 to a low of 11897.33% in Q4 2024.